Kursprognose für Telix Pharmaceuticals Ltd (TLX)TLXTelix Pharmaceuticals Ltd

Alphio's TLX stock price prediction model matches the current Telix Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.82 (+1.21%). The 1-week path is $10.73 (+0.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Telix Pharmaceuticals is currently not a strong buy due to its low RSI of 39.41, indicating oversold conditions, and a forward P/E ratio of 140.85, suggesting overvaluation. However, the recent FDA approval of Pixclara and the acquisition of ITM for $2.35 billion could drive future growth. The main risk is the high forward P/E, which reflects market skepticism about future earnings growth.

Telix Pharmaceuticals Ltd (TLX) last closed at $10.69, gaining +1.14%. These facts feed the 1-day and 1-week TLX price prediction above.